{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:43:53Z","timestamp":1788983033951,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872766"],"award-info":[{"award-number":["81872766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2021JH1\/10400049"],"award-info":[{"award-number":["2021JH1\/10400049"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bioorg.2021.105509","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T11:32:16Z","timestamp":1637580736000},"page":"105509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo"],"prefix":"10.1016","volume":"119","author":[{"given":"Xiao-Qi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Dong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105509_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J. Clinicians"},{"key":"10.1016\/j.bioorg.2021.105509_b0010","first-page":"442","article-title":"New treatment modalities for hepatocellular cancer","volume":"17","author":"Mauer","year":"2015","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105509_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/hepr.13259","article-title":"Recent advances in medical management of hepatocellular carcinoma","volume":"49","author":"Ikeda","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bioorg.2021.105509_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diff.2019.04.001","article-title":"Roles of mitochondria in liver cancer stem cells","volume":"107","author":"Chang","year":"2019","journal-title":"Differentiation."},{"key":"10.1016\/j.bioorg.2021.105509_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105509_b0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105509_b0035","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.2174\/1381612824666180903110802","article-title":"Chemical constituents and pharmacological activities of Stellera chamaejasme","volume":"24","author":"Li","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2021.105509_b0040","doi-asserted-by":"crossref","unstructured":"Y. Wang, S. Zhang, F. Li, Y. Zhou, Y. Zhang, Z. Wang, et al., Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics, Nucleic Acids Res. 2020;48:D1031-D41.","DOI":"10.1093\/nar\/gkz981"},{"key":"10.1016\/j.bioorg.2021.105509_b0045","doi-asserted-by":"crossref","unstructured":"D. Gfeller, A. Grosdidier, M. Wirth, A. Daina, O. Michielin, V. Zoete, SwissTargetPrediction: a web server for target prediction of bioactive small molecules, Nucleic Acids Res. 2014;42:W32-8.","DOI":"10.1093\/nar\/gku293"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105509_b0050","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2021.105509_b0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fitote.2014.10.002","article-title":"Cytotoxic biflavones from Stellera chamaejasme","volume":"99","author":"Wang","year":"2014","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.bioorg.2021.105509_b0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/cbdv.200890130","article-title":"Flavonoids, and coumarins from the roots of stellera chamaejasme and their antiviral effect on hepatitis B","volume":"5","author":"Yang","year":"2008","journal-title":"Virus Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2021.105509_b0065","first-page":"12","article-title":"Chemical constituents from roots of Stellera chamaejasme","volume":"35","author":"Feng","year":"2004","journal-title":"Chin. Traditional Herbal Drugs."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105509_b0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/ijms13011029","article-title":"Structural elucidation and bioactivity of biflavonoids from the stems of Wikstroemia taiwanensis","volume":"13","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105509_b0075","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"6141","key":"10.1016\/j.bioorg.2021.105509_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.105509_b0085","first-page":"925","article-title":"The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development","volume":"1","author":"Chou","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bioorg.2021.105509_b0090","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12147","article-title":"LY294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K\/AKT\/HIF1alpha pathway","volume":"24","author":"Xu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2021.105509_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.35524","article-title":"Oxaliplatin-related side effects: characteristics and management","volume":"29","author":"Cassidy","year":"2002","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105509_b0100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.29496","article-title":"Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma","volume":"67","author":"Bouattour","year":"2018","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105509_b0105","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105509_b0110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/cancers6031736","article-title":"The c-Met inhibitor MSC2156119J effectively inhibits tumor growth in liver cancer models","volume":"6","author":"Bladt","year":"2014","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bioorg.2021.105509_b0115","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919889001","article-title":"A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma","volume":"11","author":"Qin","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bioorg.2021.105509_b0120","doi-asserted-by":"crossref","first-page":"ix45","DOI":"10.1093\/annonc\/mdz422.005","article-title":"Outcomes based on albumin-bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2021.105509_b0125","doi-asserted-by":"crossref","first-page":"viii235","DOI":"10.1093\/annonc\/mdy282.081","article-title":"Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC)","volume":"29","author":"Decaens","year":"2018","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105509_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1875-8","article-title":"Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF\/NRAS mutation status","volume":"10","author":"Das","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105509_b0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10637-017-0513-5","article-title":"Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer","volume":"36","author":"Kato","year":"2018","journal-title":"Invest. New Drugs"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:33:25Z","timestamp":1758616405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821008877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":27,"alternative-id":["S0045206821008877"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105509","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105509"}}